What Is GLP-1 and Why Does It Matter for Weight Management?

Expert Review By Dr. Kathleen Valenton, MD, Double-Board Certified OB/GYN

10 min read · Published: March 17, 2026

Overview

GLP-1 is having a cultural moment…but it's been quietly shaping metabolic health research for decades. If you've seen the headlines about GLP-1 receptor agonist medications, you may have found yourself wondering: what exactly is GLP-1, how does it work, and what can you do to support your body's own GLP-1 production naturally?

This guide breaks it all down: the biology of GLP-1, why it plays such a central role in appetite regulation and metabolic health, and how Lemme Reset's three clinically studied ingredients each contribute to metabolic health and weight management support — including how Eriomin, a lemon bioflavonoid extract, specifically supports the body's natural GLP-1 production.*

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1, an incretin hormone produced primarily by specialized L-cells lining the small intestine and colon. After you eat, particularly after consuming carbohydrates, proteins, and fats, these L-cells release GLP-1 into the bloodstream, where it begins coordinating a cascade of metabolic responses.

GLP-1's roles in the body include:

•   Stimulating insulin secretion from the pancreas in a glucose-dependent manner

•   Suppressing glucagon (which otherwise drives the liver to release stored glucose)

•   Slowing gastric emptying, which prolongs feelings of fullness

•   Signaling satiety centers in the brain to reduce appetite

•   Supporting healthy blood glucose levels already in the normal range

GLP-1's challenge is that it has a very short half-life in the bloodstream (typically just 2 minutes) before an enzyme called DPP-4 breaks it down. This means the body must continually produce it to maintain its effects. Supporting the conditions that promote GLP-1 production is therefore a meaningful goal for anyone focused on metabolic health and weight management.

GLP-1 Receptor Agonist Medications vs. Supporting Natural GLP-1 Production

GLP-1 receptor agonist medications (like semaglutide and liraglutide) are prescription drugs that work by introducing a synthetic GLP-1 analog into the bloodstream at pharmacological concentrations far exceeding what the body produces naturally. They are regulated pharmaceutical interventions that require a prescription, ongoing medical supervision, and carry meaningful side effect profiles that differ significantly from person to person.

It is important to be clear: the effects of pharmaceutical GLP-1 receptor agonist drugs are substantially stronger than anything a dietary supplement can produce. These are not comparable interventions, and no supplement, including Lemme Reset, should be understood as equivalent to, or a substitute for, a prescription GLP-1 medication. If you are considering a GLP-1 receptor agonist drug, that is a conversation to have with your physician.

Supporting the body's own GLP-1 production through supplementation is a fundamentally different and more modest approach. Rather than introducing a synthetic GLP-1 compound, it focuses on supporting the natural conditions under which the body's intestinal L-cells produce GLP-1 in response to food intake. The ingredient in Lemme Reset studied for this purpose is Eriomin, a patented lemon flavonoid extract with published human clinical trial data on GLP-1 production support.

Lemme Reset™ does not contain GLP-1 or any synthetic GLP-1 compound. It is not a GLP-1 receptor agonist drug. It is a supplement formulated to support the body’s own GLP-1 production through clinically studied ingredients. 

The Three Clinically Studied Ingredients in Lemme Reset

Lemme Reset is formulated with three patented, clinically studied ingredients,  each with its own published research supporting its role in metabolic health and weight management:

1. Eriomin® — Lemon Flavonoid Extract (GLP-1 Production Support)

Eriomin is a patented extract standardized to 70% eriocitrin, a flavonoid compound found in lemon peel. Across three published randomized controlled trials, Eriomin supplementation at 200mg/day was associated with increased GLP-1 production by an average of 17.5% compared to placebo. Researchers also observed improvements in glucose metabolism markers. The GLP-1 increase observed with Eriomin appears to reflect a sustained, building effect over 12 weeks — not a single-dose spike.

2. Morosil™ — Moro Blood Orange Extract (Body Composition & Fat Management)

Morosil is a standardized extract derived from Moro blood oranges, a specific cultivar grown in Sicily rich in anthocyanins, including cyanidin-3-glucoside. In a randomized, double-blind, placebo-controlled study over 6 months in overweight but otherwise healthy adults, supplementation with Moro blood orange extract was associated with significantly greater improvements in body mass, BMI, waist circumference, hip circumference, and fat distribution (including both visceral and subcutaneous fat) compared to placebo. These results were achieved in combination with diet and exercise.

3. Supresa® — Saffron Extract (Appetite & Craving Support)

Supresa is a patented saffron extract (Crocus sativus L.) standardized to safranal, crocin, and picrocrocin, the bioactive compounds responsible for its effects on serotonin pathways in the brain. In a double-blind, placebo-controlled study of 60 healthy women over 8 weeks at the clinical dose of 176.5mg/day: 69% of participants reported feeling less hungry, 70% reported lower appetite, and snacking episodes decreased by 55% compared to placebo. Supresa works through serotonin modulation, promoting natural satiety signals rather than forced appetite suppression.

Why GLP-1 Production Support Matters for Women

Women face unique metabolic challenges across different life stages, from hormonal fluctuations during the menstrual cycle and perimenopause to the metabolic shifts that accompany postpartum recovery. GLP-1 secretion can be influenced by gut microbiome composition, inflammatory tone, and insulin sensitivity, all areas where women's physiology is particularly dynamic.

Supporting GLP-1 production naturally, through the gut-intestinal pathway using ingredients like Eriomin in Lemme Reset, aligns with a whole-body approach to metabolic health that is especially relevant for women.

Dr. Valenton's perspective: "GLP-1 is a meaningful target for women's metabolic health. For my patients interested in evidence-informed approaches to weight management support, I look for ingredients with published human clinical data at the studied dose. Lemme Reset's three-ingredient approach, supporting GLP-1 production, body composition, and appetite signaling, represents a thoughtful, multi-pathway strategy."

Frequently Asked Questions

Is Lemme Reset a GLP-1 drug like Ozempic or Wegovy?

No. Lemme Reset is a dietary supplement, not a pharmaceutical drug. It does not contain GLP-1 or any synthetic GLP-1 analog. It is not a GLP-1 receptor agonist. The effects of prescription GLP-1 medications are substantially stronger than any dietary supplement. These are not comparable interventions. Lemme Reset contains three clinically studied ingredients that each support different aspects of metabolic health: Eriomin for GLP-1 production support, Morosil for body composition support, and Supresa for appetite management. Prescription GLP-1 receptor agonist medications are entirely separate; they are pharmaceutical drugs that require a prescription and medical supervision.

How does Eriomin support GLP-1 production?

Eriomin contains eriocitrin, a citrus flavonoid that research suggests supports GLP-1 secretion through its effects on gut microbiota composition and glucose metabolism. Across multiple clinical trials at 200mg/day, Eriomin was associated with GLP-1 production increases averaging 17.5% compared to placebo over 12 weeks.

How long does Lemme Reset take to work?

Based on the clinical studies of the individual ingredients, the effects of Eriomin on GLP-1 production appear to build over 12 weeks of consistent use. The Supresa clinical study observed reductions in snacking beginning within 14 days in women identified as regular snackers. Individual results will vary.

Can I take Lemme Reset with other medications?

Always consult your healthcare provider before starting any new supplement, particularly if you are taking prescription medications. 

Is Lemme Reset formulated with the same doses used in the clinical studies?

Yes. Lemme Reset contains each ingredient at its clinically studied dose: 200mg Eriomin, 400mg Morosil, and 176.5mg Supresa — the same doses used in the published clinical trials.

Important Information

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement regimen.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Citations & References

1. Ribeiro CB, et al. Effectiveness of Eriomin in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study. Food Sci Nutr. 2019;7(8):2750-2760. https://pubmed.ncbi.nlm.nih.gov/31428338

2. Cesar TB, Ramos FMM, Ribeiro CB. Nutraceutical eriocitrin (Eriomin) reduces hyperglycemia by increasing glucagon-like peptide 1 and downregulates systemic inflammation: A crossover-randomized clinical trial. J Med Food. 2022;25(11):1050-1058. https://pubmed.ncbi.nlm.nih.gov/35796695

3. Ramos FM, et al. Lemon flavonoids nutraceutical (Eriomin) attenuates prediabetes intestinal dysbiosis: A double-blind randomized controlled trial. Food Sci Nutr. 2023. https://pubmed.ncbi.nlm.nih.gov/37970408

4. Cardile V, et al. Clinical evaluation of Moro (Citrus sinensis) orange juice supplementation for the weight management. Lipids Health Dis. 2015;14:37. https://pubmed.ncbi.nlm.nih.gov/25588369

5. Zangara A, et al. Effectiveness of Moro Blood Orange Citrus sinensis Standardized Extract on Weight Loss in Overweight but Otherwise Healthy Men and Women. Nutrients. 2022;14(3):427. https://pubmed.ncbi.nlm.nih.gov/35276783

6. Gout B, Bourges C, Paineau-Dubreuil S. Satiereal/Supresa, a Crocus sativus L. extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010;30(5):305-313. https://pubmed.ncbi.nlm.nih.gov/20579522

7. Drucker DJ. The biology of incretin hormones. Cell Metab. 2006;3(3):153-165. https://pubmed.ncbi.nlm.nih.gov/16517403

About the Expert Reviewer

Kathleen Valenton, MD is a double board-certified OB/GYN at Rodeo Drive Women's Health Center in Beverly Hills, CA, with over a decade of experience in women's health. She completed her internship and residency at Cedars-Sinai Medical Center — where she remains an attending physician — after earning her Medical Degree from the University of Vermont College of Medicine and dual Bachelor's and Master's degrees in Psychology from UC Berkeley. Dr. Valenton is also the Chief Medical Officer at Lemme. Her clinical research interests span mental health, hormonal health, infertility, PCOS, and menopause. Dr. Valenton is known for her expertise in pelvic pain, infertility evaluations, and minimally invasive surgery, and remains actively involved in resident education and physician-nursing collaboratives at Cedars-Sinai.